Predictive value of preprocedural fibrinogen concerning coronary stenting

Atherosclerosis

Volumn 164, Issue 2, 2002, Pages 371-378

  Otsuka, Masaya ^a   Hayashi, Yasuhiko ^b   Ueda, Hironori ^b   Imazu, Michinori ^c   Kohno, Nobuoki ^c  

^a 11 40 Hijiyamahonmachi   (Japan)

^b TSUCHIYA GENERAL HOSPITAL   (Japan)

^c HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

C reactive protein; Coronary stenting; Fibrinogen; Predictor; Restenosis

Indexed keywords

FIBRINOGEN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD CLOTTING; CAUSE OF DEATH; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; CORONARY STENT; DEATH; DISEASE ASSOCIATION; EVALUATION; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; RESTENOSIS;

AGED; ANALYSIS OF VARIANCE; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; COHORT STUDIES; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY STENOSIS; FEMALE; FIBRINOGEN; HEART FUNCTION TESTS; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; STENTS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 0036801617     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00177-6     Document Type: Article

References (42)

1. Wilhelmsen L.S.K., Korsan-Bengtsen K., Larsson B., Welin L., Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 311:1984;501-505.
2. Kannel W.B.W.P., Castelli W.P., D'Agostino R.B. Fibrinogen and risk of cardiovascular disease. The Framingham Study. J. Am. Med. Assoc. 258:1987;1183-1186.
3. Yarnell J.W., Baker I.A., Sweetnam P.M., et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies. Circulation. 83:1991;836-844.
4. ECAT angina pectoris study: Baseline associations of haemostatic factors with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography, Eur Heart J 1993;14:8-17.
5. Broadhurst P., Kelleher C., Hughes L., Imeson J.D., Raftery E.B. Fibrinogen, factor VII clotting activity and coronary artery disease severity. Atherosclerosis. 85:1990;169-173.
6. Handa K., Kono S., Saku K., et al. Plasma fibrinogen levels as an independent indicator of severity of coronary atherosclerosis. Atherosclerosis. 77:1989;209-213.
7. Toss H., Lindahl B., Siegbahn A., Wallentin L. Prognostic influence of increased fibrinogen and C-reactive protein levels in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. Circulation. 96:1997;4204-4210.
8. Haines A.P., Howarth D., North W.R., et al. Haemostatic variables and the outcome of myocardial infarction. Thromb. Haemost. 50:1983;800-803.
9. Cristal N., Slonim A., Bar-Ilan I., Hart A. Plasma fibrinogen levels and the clinical course of acute myocardial infarction. Angiology. 34:1983;693-698.
10. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
11. Montalescot G., Ankri A., Vicaut E., Drobinski G., Grosgogeat Y., Thomas D. Fibrinogen after coronary angioplasty as a risk factor for restenosis. Circulation. 92:1995;31-38.
12. Benchimol D., Bonnet J., Benchimol H., et al. Biological risk factors for restenosis after percutaneous transluminal coronary angioplasty. Int. J. Cardiol. 38:1993;7-18.
13. Fischman D.L., Leon M.B., Baim D.S., et al. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators. N. Engl. J. Med. 331:1994;496-501.
14. Serruys P.W., de Jaegere P., Kiemeneij F., et al. A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group. N. Engl. J. Med. 331:1994;489-495.
15. Kornowski R., Hong M.K., Tio F.O., Bramwell O., Wu H., Leon M.B. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J. Am. Coll. Cardiol. 31:1998;224-230.
16. Lablanche J.M., McFadden E.P., Bonnet J.L., et al. Combined antiplatelet therapy with ticlopidine and aspirin. A simplified approach to intracoronary stent management. Eur. Heart J. 17:1996;1373-1380.
17. Reiber JHCSP. Progress in Quantitative Coronary Arteriography. Dordrecht, (The Netherlands): Kluwer 1994.
18. Schachinger V., Allert M., Kasper W., Just H., Vach W., Zeiher A.M. Adjunctive intracoronary infusion of antithrombin III during percutaneous transluminal coronary angioplasty. Results of a prospective, randomized trial. Circulation. 90:1994;2258-2266.
19. Hata Y., Mabuchi H., Saito Y., et al. Report of the Japan Atherosclerosis Society (JAS) Guideline for Diagnosis and Treatment of Hyperlipidemia in Japanese Adults. J. Atheroscler. Thromb. 9:2002;1-27.
20. The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985;312:932-936.
21. Clauss A. Gerinnungsphysiologishe Schnellmethode zur Bestimmung des Fibrinogens. Acuta. Haematol. 17:1957;237-246.
22. Kastrati A.S.A., Elezi S., Schuhlen H., et al. Predictive factors of restenosis after coronary stent placement. J. Am. Coll. Cardiol. 30:1997;1428-1436.
23. Elezi S.K.A., Neumann F.J., Hadamitzky M., et al. Vessel size and long-term outcome after coronary stent placement. Circulation. 98:1998;1875-1880.
24. Bauters C.H.E., Prat A., Bougrimi K., et al. Predictors of restenosis after coronary stent implantation. J. Am. Coll. Cardiol. 31:1998;1291-1298.
25. Rau T.S.J., Schluter M., Seidensticker A., Berger J., Mathey D.G. Stenting of nonacute total coronary occlusions: predictors of late angiographic outcome. J. Am. Coll. Cardiol. 31:1998;275-280.
26. Kobayashi Y., De Gregorio J., Kobayashi N., et al. Stented segment length as an independent predictor of restenosis. J. Am. Coll. Cardiol. 34:1999;651-659.
27. Kastrati A.E.S., Dirschinger J., Hadamitzky M., Neumann F.J., Schomig A. Influence of lesion length on restenosis after coronary stent placement. Am. J. Cardiol. 83:1999;1617-1622.
28. Kastrati A., Mehilli J., Dirschinger J., et al. Restenosis after coronary placement of various stent types. Am. J. Cardiol. 87:2001;34-39.
29. Schwartz R.S., Edwards W.D., Bailey K.R., Camrud A.R., Jorgenson M.A., Holmes D.R. Differential neointimal response to coronary artery injury in pigs and dogs. Implications for restenosis models. Arterioscler. Thromb. 14:1994;395-400.
30. Schwartz S.M., deBlois D., O'Brien E.R. The intima. Soil for atherosclerosis and restenosis. Circ. Res. 77:1995;445-465.
31. Raymond J., Desfaits A.C., Roy D. Fibrinogen and vascular smooth muscle cell grafts promote healing of experimental aneurysms treated by embolization. Stroke. 30:1999;1657-1664.
32. Kawasaki T., Dewerchin M., Lijnen H.R., Vreys I., Vermylen J., Hoylaerts M.F. Mouse carotid artery ligation induces platelet-leukocyte-dependent luminal fibrin, required for neointima development. Circ. Res. 88:2001;159-166.
33. Komatsu R., Ueda M., Naruko T., Kojima A., Becker A.E. Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. Circulation. 98:1998;224-233.
34. Gaspardone A., Crea F., Versaci F., et al. Predictive value of C-reactive protein after successful coronary-artery stenting in patients with stable angina. Am. J. Cardiol. 82:1998;515-518.
35. Versaci F, Gaspardone A, Tomai F, Crea F, Chiariello L, Gioffre PA. Predictive value of C-reactive protein in patients with unstable angina pectoris undergoing coronary artery stent implantation, Am J Cardiol 2000;85:92-5, A8.
36. Walter D.H., Fichtlscherer S., Sellwig M., Auch-Schwelk W., Schächinger V., Zeiher A.M. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. J. Am. Coll. Cardiol. 37:2001;839-846.
37. Thompson S.G., Kienast J., Pyke S.D., Haverkate F., van de Loo J.C. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European concerted action on thrombosis and disabilities angina pectoris study group. N. Engl. J. Med. 332:1995;635-641.
38. Ryan T.J., Antman E.M., Brooks N.H., et al. Update: ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J. Am. Coll. Cardiol. 34:1999;890-911.
39. Elezi S.K.A., Pache J., Wehinger A., Hadamitzky M., Dirschinger J., Neumann F.J., Schomig A. Diabetes mellitus and the clinical and angiographic outcome after coronary stent placement. J. Am. Coll. Cardiol. 32:1998;1866-1873.
40. Ribichini F., Steffenino G., Dellavalle A., et al. Plasma activity and insertion/deletion polymorphism of angiotensin I-converting enzyme: a major risk factor and a marker of risk for coronary stent restenosis. Circulation. 97:1998;147-154.
41. Abizaid A., Kornowski R., Mintz G.S., et al. The influence of diabetes mellitus on acute and late clinical outcomes following coronary stent implantation. J. Am. Coll. Cardiol. 32:1998;584-589.
42. Aronson D., Bloomgarden Z., Rayfield E.J. Potential mechanisms promoting restenosis in diabetic patients. J. Am. Coll. Cardiol. 27:1996;528-535.